Integrin αIIbβ3

Platelets

Volumn , Issue , 2007, Pages 165-178

  Plow, Edward F ^a   Pesho, Michelle M ^a   Ma, Yan Qing ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 73149093011     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369367-9/50770-9     Document Type: Chapter

References (184)

1. Adams P.C., Badimon J.J., Badimon L., Chesebro J.H., Fuster V. Role of platelets in atherogenesis: Relevance to coronary arterial restenosis after angioplasty. Cardiovasc Clin 1987, 18:49-71.
2. Ross R. Atherosclerosis: A defense mechanism gone awry. Am J Pathol 1993, 143:987-1002.
3. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995, 91:2844-2850.
4. Bennett J.S. The molecular biology of platelet membrane proteins. Semin Hematol 1990, 27:186-204.
5. Plow E.F., Byzova T. The biology of glycoprotein IIb-IIIa. Coron Artery Dis 1999, 10:547-551.
6. Plow E.F., D'Souza S.E., Ginsberg M.H. Ligand binding to GPIIb-IIIa: A status report. Semin Thromb Hemost 1992, 18:324-332.
7. Savage B., Cattaneo M., Ruggeri Z.M. Mechanisms of platelet aggregation. Curr Opin Hematol 2001, 8:270-276.
8. Hynes R.O. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992, 69:11-25.
9. Plow E.F., Haas T.A., Zhang L., Loftus J., Smith J.W. Ligand binding to integrins. J Biol Chem 2000, 275:21785-21788.
10. Plow E.F., Shattil S.J. Integrin αIIbβ3 and platelet aggregation. Hemostasis and thrombosis: Basic principles and clinical practice 2001, 479-491. Lippincott Williams & Wilkins, Philadelphia. R.W. Colman, J. Hirsh, V.J. Marder, A.W. Clowes, J.N. George (Eds.).
11. Plow E.F., Marguerie G.A. Inhibition of fi brinogen binding to human platelets by the tetrapeptide glycyl-Lprolyl-L-arginyl-L-proline. Proc Natl Acad Sci USA 1982, 79:3711-3715.
12. Coller B.S., Peerschke E.I., Scudder L.E., Sullivan C.A. A murine monoclonal antibody that completely blocks the binding of fi brinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest 1983, 72:325-338.
13. Bhatt D.L., Topol E.J. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. J Am Med Assoc 2000, 284:1549-1558.
14. Hynes R.O. Integrins: Bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
15. Smith J.W., Piotrowicz R.S., Mathis D. A mechanism for divalent cation regulation of β3-integrins. J Biol Chem 1994, 269:960-967.
16. Lam S.C., Plow E.F., D'Souza S.E., et al. Isolation and characterization of a platelet membrane protein related to the vitronectin receptor. J Biol Chem 1989, 264:3742-3749.
17. Lawler J., Hynes R.O. An integrin receptor on normal and thrombasthenic platelets that bind thrombospondin. Blood 1989, 74:2022-2027.
18. Uzan G., Prenant M., Prandini M.-H., Martin F., Marguerie G. Tissue-specific expression of the platelet GPIIb gene. J Biol Chem 1991, 266(14):8932-8939.
19. Trikha M., Timar J., Lundy S.K., et al. Human prostate carcinoma cells express functional αIIbβ3 integrin. Cancer Res 1996, 56:5071-5078.
20. Butler-Zimrin A.E., Bennett J.S., Poncz M., et al. Isolation and characterization of cDNA clones for the platelet membrane glycoproteins IIb and IIIa. Thromb Haemost 1987, 58:319a.
21. Cheresh D.A. Structural and biologic properties of integrin-mediated cell adhesion. Clin Lab Med 1992, 12:217.
22. Phillips D.R., Charo I.F., Parise L.V., Fitzgerald L.A. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988, 71:831-843.
23. Niiya K., Hodson E., Bader R., et al. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fi brinogen and platelet aggregation. Blood 1987, 70:475-483.
24. Wagner C.L., Mascelli M.A., Neblock D.S., et al. Analysis of GPIIb/IIIa receptor number by quanitifi cation of 7E3 binding to human platelets. Blood 1996, 88:907-914.
25. Stouffer G.A., Smyth S.S. Effects of thrombin on interactions between beta3-integrins and extracellular matrix in platelets and vascular cells. Arterioscler Thromb Vasc Biol 2003, 23:1971-1978.
26. Wencel-Drake J.D., Plow E.F., Kunicki T.J., et al. Localization of internal pools of membrane glycoproteins involved in platelet adhesive responses. Am J Pathol 1986, 124:324-334.
27. Woods V.L., Wolff L.E., Keller D.M. Resting platelets contain a substantial centrally located pool of glycoprotein IIb-IIIa complex which may be accessible to some but not other extracellular proteins. J Biol Chem 1986, 261:15242-15251.
28. Fujimura K., Phillips D.R. Calcium cation regulation of glycoprotein IIb-IIIa complex formation in platelet plasma membranes. J Biol Chem 1983, 258:10247-10252.
29. Sosnoski D.M., Emanuel B.S., Hawkins A.L., et al. Chromosomal localization of the genes for the vitronectin and fibronectin receptors α subunits and for platelet glycoproteins IIb and IIIa. J Clin Invest 1988, 81:1993-1998.
30. Duperray A., Berthier R., Chagnon E., et al. Biosynthesis and processing of platelet GPIIb-IIIa in human megakaryocytes. J Cell Biol 1987, 104:1665-1673.
31. Loftus J.C., Plow E.F., Jennings L.K., Ginsberg M.H. Alternative proteolytic processing of platelet membrane GPIIb. J Biol Chem 1988, 263:11025-11028.
32. Poncz M., Eisman R., Heidenreich R., et al. Structure of the platelet membrane glycoprotein IIb. Homology to the alpha subunits of the vitronectin and fibronectin membrane receptors. J Biol Chem 1987, 262:8476-8482.
33. Zimrin A.B., Gidwitz S., Lord S., et al. The genomic organization of platelet glycoprotein IIIa. J Biol Chem 1990, 265:8590-8595.
34. Fitzgerald L.A., Steiner B., Rall S.C.J., Lo S.S., Phillips D.R. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. Identity with platelet glycoprotein IIIa and similarity to "integrin.". J Biol Chem 1987, 262:3936-3939.
35. Xiong J.P., Stehle T., Diefenbach B., et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science 2001, 294:339-345.
36. Xiao T., Takagi J., Coller B.S., Wang J.H., Springer T.A. Structural basis for allostery in integrins and binding to fi brinogen-mimetic therapeutics. Nature 2004, 432:59-67.
37. Xiong J.P., Stehle T., Zhang R., et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science 2002, 296:151-155.
38. Xiong J.P., Stehle T., Goodman S.L., Arnaout M.A. Integrins, cations and ligands: Making the connection. J Thromb Haemost 2003, 7:1642-1654.
39. Chothia C., Jones E.Y. The molecular structure of cell adhesion molecules. Annu Rev Biochem 1997, 66:823-862.
40. Carrell N.A., Fitzgerald L.A., Steiner B., Erickson H.P., Phillips D.R. Structure of human platelet membrane glycoproteins IIb and IIIa as determined by electron microscopy. J Biol Chem 1985, 260:1743-1749.
41. Weisel J.W., Nagaswami C., Vilaire G., Bennett J.S. Examination of the platelet membrane GPIIb-IIIa complex and its interaction with fi brinogen and other ligands by electron microscopy. J Biol Chem 1992, 267:16637-16643.
42. Vinogradova O., Haas T., Plow E.F., Qin J. A structural basis for integrin activation by the cytoplasmic tail of the alpha IIb-subunit. Proc Natl Acad Sci USA 2000, 97:1450-1455.
43. Vinogradova O., Velyvis A., Velyviene A., et al. A structural mechanism of integrin αIIbβ3 "inside-out" activation as regulated by its cytoplasmic face. Cell 2002, 110:587-597.
44. Vinogradova O., Vaynberg J., Kong X., et al. Membrane-mediated structural transitions at the cytoplasmic face during integrin activation. Proc Natl Acad Sci USA 2004, 101:4094-4099.
45. Ulmer T.S., Yaspan B., Ginsberg M.H., Campbell I.D. NMR analysis of structure and dynamics of the cytosolic tails of integrin alphaIIbbeta3 in aqueous solution. Biochemistry 2001, 40:7498-7508.
46. Beglova N., Blacklow S.C. The LDL receptor: How acid pulls the trigger. Trends Biochem Sci 2005, 30:309-317.
47. Partridge A.W., Liu S., Kim S., Bowie J.U., Ginsberg M.H. Transmembrane domain helix packing stabilizes integrin alphaIIbbeta3 in the low affinity state. J Biol Chem 2005, 280:7294-7300.
48. Ruoslahti E. Integrins. J Clin Invest 1991, 87:1-5.
49. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Biol 1996, 12:697-715.
50. Felding-Habermann B., Ruggeri Z.M., Cheresh D.A. Distinct biological consequences of integrin αvβ3-mediated melanoma cell adhesion to fi brinogen and its plasmic fragments. J Biol Chem 1992, 267:5070-5077.
51. Cheresh D.A., Berliner S.A., Vicente V., Ruggeri Z.M. Recognition of distinct adhesive sites on fi brinogen by related integrins on platelets and endothelial cells. Cell 1989, 58:945-953.
52. Suehiro K., Gailit J., Plow E.F. Fibrinogen is a ligand for integrin α5β1 on endothelial cells. J Biol Chem 1997, 272:5360-5366.
53. Farrell D.H., Thiagarajan P., Chung D.W., Davie E.W. Role of fi brinogen alpha and gamma chain sites in platelet aggregation. Proc Natl Acad Sci USA 1992, 89:10729-10732.
54. Beacham D.A., Wise R.J., Turci S.M., Handin R.I. Selective inactivation of the arg-gly-asp-ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis. J Biol Chem 1992, 267:3409-3415.
55. Cierniewski C.S., Byzova T., Papierak M., et al. Peptide ligands can bind to distinct sites in integrin αIIbβ3 and elicit different functional responses. J Biol Chem 1999, 274:16923-16932.
56. Farrell D.H., Thiagarajan P. Binding of recombinant fi brinogen mutants to platelets. J Biol Chem 1994, 269:226-231.
57. Smith R.A., Mosesson M.W., Rooney M.M., et al. The role of putative fi brinogen Aα-, Bβ-, and gammaAchain integrin binding sites in endothelial cell-mediated clot retraction. J Biol Chem 1997, 272:22080-22085.
58. Mustard J.F., Packham M.A., Kinlough-Rathbone R.L., Perry D.W., Regoeczi E. Fibrinogen and ADPinduced platelet aggregation. Blood 1978, 52:453-465.
59. Marguerie G.A., Edgington T.S., Plow E.F. Interaction of fi brinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. J Biol Chem 1980, 255:154-161.
60. Bennett J.S., Vilaire G. Exposure of platelet fi brinogen receptors by ADP and epinephrine. J Clin Invest 1979, 64:1393-1401.
61. Takagi J., Petre B.M., Walz T., Springer T.A. Global conformational rearrangements in integrin extracel-lular domains in outside-in and inside-out signaling. Cell 2002, 110:599-611.
62. Luo B.H., Takagi J., Springer T.A. Locking the beta3 integrin I-like domain into high and low affinity conformations with disulfi des. J Biol Chem 2004, 279:10215-10221.
63. Takagi J., DeBottis D.P., Erickson H.P., Springer T.A. The role of the specificity-determining loop of the integrin beta subunit I-like domain in autonomous expression, association with the alpha subunit, and ligand binding. Biochemistry 2002, 41:4339-4347.
64. Adair B.D., Xiong J.P., Maddock C., et al. Threedimensional EM structure of the ectodomain of integrin αVβ3 in a complex with fibronectin. J Cell Biol 2005, 168:1109-1118.
65. Hato T., Pampori N., Shattil S.J. Complementary roles for receptor clustering and conformational change in the adhesive and signaling functions of integrin αIIbβ3. J Cell Biol 1998, 141:1685-1695.
66. Buensucesco C., de Virgilio M., Shattil S.J. Detection of integrin alpha IIbbeta 3 clustering in living cells. J Biol Chem 2003, 278:15217-15224.
67. Ginsberg M.H., Du X., Plow E.F. Inside-out integrin signaling. Curr Opin Cell Biol 1992, 4:766.
68. O'Toole T.E., Katagiri Y., Faull R.J., et al. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 1994, 124:1047-1059.
69. Schwartz M.A., Schaller M.D., Ginsberg M.H. Integrins: Emerging paradigms of signal transduction. Annu Rev Cell Biol 1995, 11:549-599.
70. Shattil S.J., Ginsberg M.H., Brugge J.S. Adhesive signaling in platelets. Curr Opin Cell Biol 1994, 6:695-704.
71. Clark E.A., Brugge J.S. Integrins and signal transduction pathways: The road taken. Science 1995, 268:233-239.
72. Frelinger A.L., Lam S.C.T., Plow E.F., et al. Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. J Biol Chem 1988, 263:12397-12402.
73. Parise L.V., Helgerson S.L., Steiner B., Nannizzi L., Phillips D.R. Synthetic peptides derived from fi brinogen and fibronectin change the conformation of puri-fi ed platelet glycoprotein IIb-IIIa. J Biol Chem 1987, 262:12597-12602.
74. Dedhar S., Hannigan G.E. Integrin cytoplasmic interactions and bidirectional transmembrane signalling. Curr Opin Cell Biol 1996, 8:657-669.
75. Qin J., Vinogradova O., Plow E.F. Integrin bidirectional signaling: A molecular view. PLoS Biol 2004, 2:e169.
76. Packham M.A., Guccione M.A., Greenberg J.P., Kinlough-Rathbone R.L., Mustard J.F. Release of 14C-serotonin during initial platelet changes induced by thrombin, collagen, or A23187. Blood 1977, 50:915-926.
77. Moroi M., Jung S.M. Platelet glycoprotein VI: Its structure and function. Thromb Res 2004, 114:221-233.
78. Nieswandt B., Watson S.P. Platelet-collagen interaction: Is GPVI the central receptor?. Blood 2003, 102:449-461.
79. Poole A., Gibbins J.M., Turner M., et al. The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 1997, 16:2333-2341.
80. Shattil S.J., Brass L.F. Induction of the fi brinogen receptor on human platelets by intracellular mediators. J Biol Chem 1987, 262:992-1000.
81. Asazuma N., Wilde J.I., Berlanga O., et al. Interaction of linker for activation of T cells with multiple adapter proteins in platelets activated by the glycoprotein VI-selective ligand, convulxin. J Biol Chem 2000, 275:33427-33434.
82. Falet H., Barkalow K.L., Pivniouk V.I., et al. Roles of SLP-76, phosphoinositide 3-kinase, and gelsolin in the platelet shape changes initiated by the collagen receptor GPVI/FcR gamma-chain complex. Blood 2000, 96:3786-3792.
83. Zheng Y.M., Liu C., Chen H., et al. Expression of the platelet receptor GPVI confers signaling via the Fc receptor gamma-chain in response to the snake venom convulxin but not to collagen. J Biol Chem 2001, 276:12999-13006.
84. Nieuwenhuis H.K., Akkerman J.W.N., Houdijk W.P.M., Sixma J.J. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 1985, 318:470-472.
85. Holtkotter O., Nieswandt B., Smyth N., et al. Integrin alpha 2-defi cient mice develop normally, are fertile, but display partially defective platelet interaction with collagen. J Biol Chem 2002, 277:10789-10794.
86. Kroll M.H., Hellums J.D., McIntire L.V., Schafer A.I., Moake J.L. Platelets and shear stress. Blood 1996, 88:1525-1541.
87. Andrews R.K., Kroll M.H., Ward C.M., et al. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation. Biochemistry 1996, 35:12629-12639.
88. Feng S., Christodoulides N., Resendiz J.C., Berndt M.C., Kroll M.H. Cytoplasmic domains of GpIbalpha and GpIbbeta regulate 14-3-3zeta binding to GpIb/IX/V. Blood 2000, 95:551-557.
89. Gu M., Xi X., Englund G.D., Berndt M.C., Du X. Analysis of the roles of 14-3-3 in the platelet glycoprotein Ib-IX-mediated activation of integrin alpha (IIb) beta (3) using a reconstituted mammalian cell expression model. J Cell Biol 1999, 147:1085-1096.
90. Zaffran Y., Meyer S.C., Negrescu E., Reddy K.B., Fox J.E. Signaling across the platelet adhesion receptor glycoprotein Ib-IX induces alpha IIbbeta 3 activation both in platelets and a transfected Chinese hamster ovary cell system. J Biol Chem 2000, 275:16779-16787.
91. Chen J., Lopez J.A. Interactions of platelets with subendothelium and endothelium. Microcirculation 2005, 12:235-246.
92. Xi X., Bodnar R.J., Li Z., Lam S.C., Du X. Critical roles for the COOH-terminal NITY and RGT sequences of the integrin beta3 cytoplasmic domain in inside-out and outside-in signaling. J Cell Biol 2003, 162:329-339.
93. Kahn M.L., Zheng Y.W., Huang W., et al. A dual thrombin receptor system for platelet activation. Nature 1998, 394:690-694.
94. Xu W.F., Andersen H., Whitmore T.E., et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 1998, 95:6642-6646.
95. Vu T.K., Wheaton V.I., Hung D.T., Charo I., Coughlin S.R. Domains specifying thrombin-receptor interaction. Nature 1991, 353:674-677.
96. Hollopeter G., Jantzen H.M., Vincent D., et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001, 409:202-207.
97. Fabre J.E., Nguyen M., Latour A., et al. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-defi cient mice. Nat Med 1999, 5:1199-1202.
98. MacKenzie A.B., Mahaut-Smith M.P., Sage S.O. Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets. J Biol Chem 1996, 271:2879-2881.
99. Kunapuli S.P. Molecular physiology of platelet ADP receptors. Drug Dev Res 1998, 45:135-139.
100. Dorsam R.T., Kunapuli S.P. Central role of the P2Y12 receptor in platelet activation. J Clin Invest 2004, 113:340-345.
101. Hirata T., Ushikubi F., Kakizuka A., Okuma M., Narumiya S. Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J Clin Invest 1996, 97:949-956.
102. Abrams C.S. Intracellular signaling in platelets. Curr Opin Hematol 2005, 12:401-405.
103. Fox J.E.B., Reynolds C.C., Phillips D.R. Calcium-dependent proteolysis occurs during platelet aggregation. J Biol Chem 1983, 258:9973-9981.
104. Saido T.C., Shibata M., Takenawa T., Murofushi H., Suzuki K. Positive regulation of μ-calpain action by polyphosphoinositides. J Biol Chem 1992, 267:24585-24590.
105. Tsujinaka T., Sakon M., Kambayashi J., Kosaki G. Cleavage of cytoskeletal proteins by two forms of Ca2+ activated neutral proteases in human platelets. Thromb Res 1982, 28:149-156.
106. Suzuki K., Imajoh S., Emori Y., et al. Calciumactivated neutral protease and its endogenous inhibitor. Activation at the cell membrane and biological function. FEBS Lett 1987, 220:271-277.
107. Kawasaki H., Springett G.M., Toki S., et al. A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proc Natl Acad Sci U S A 1998, 95:13278-13283.
108. Dupuy A.J., Morgan K., von Lintig F.C., et al. Activation of the Rap1 guanine nucleotide exchange gene, CalDAG-GEF I, in BXH-2 murine myeloid leukemia. J Biol Chem 2001, 276:11804-11811.
109. Crittenden J.R., Bergmeier W., Zhang Y., et al. CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med 2004, 10:982-986.
110. Chrzanowska-Wodnicka M., Smyth S.S., Schoenwaelder S.M., Fischer T.H., White G.C. Rap1b is required for normal platelet function and hemostasis in mice. J Clin Invest 2005, 115:680-687.
111. Chen J., De S., Damron D.S., et al. Impaired platelet responses to thrombin and collagen in AKT-1-defi cient mice. Blood 2004, 104:1703-1710.
112. Woulfe D., Jiang H., Mortensen R., Yang J., Brass L.F. Activation of Rap1B by G(i) family members in platelets. J Biol Chem 2002, 27:23382-23390.
113. Rees D.J., Ades S.E., Singer S.J., Hynes R.O. Sequence and domain structure of talin. Nature 1990, 347:685-689.
114. Calderwood D.A., Zent R., Grant R., et al. The talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem 1999, 274:28071-28074.
115. Knezevic I., Leisner T.M., Lam S.C.T. Direct binding of the platelet integrin αIIbβ3 (GPIIb-IIIa) to talin: Evidence that interaction is mediated through the cytoplasmic domains of both αIIb and β3. J Biol Chem 1996, 271:16416-16421.
116. Patil S., Jedsadayanmata A., Wencel-Drake J.D., et al. Identification of a talin-binding site in the integrin beta (3) subunit distinct from the NPLY regulatory motif of post-ligand binding functions. The talin n-terminal head domain interacts with the membrane-proximal region of the beta (3) cytoplasmic tail. J Biol Chem 1999, 274:28575-28583.
117. Pfaff M., Liu S., Erle D.J., Ginsberg M.H. Integrin beta cytoplasmic domains differentially bind to cytoskeletal proteins. J Biol Chem 1998, 273:6104-6109.
118. Jenkins A.L., Nannizzi-Alaimo L., Silver D., et al. Tyrosine phosphorylation of the β3 cytoplasmic domain mediates integrin-cytoskeletal interactions. J Biol Chem 1998, 273:13878-13885.
119. Reddy K.B., Gascard P., Price M.G., Negrescu E.V., Fox J.E. Identification of an interaction between the m-band protein skelemin and beta-integrin subunits. Colocalization of a skelemin-like protein with beta1-and beta3-integrins in non-muscle cells. J Biol Chem 1998, 273:35039-35047.
120. Goldmann W.H. Kinetic determination of focal adhesion protein formation. Biochem Biophys Res Commun 2000, 271:553-557.
121. Otey C.A., Pavalko F.M., Burridge K. An interaction between alpha-actinin and the beta1 integrin subunit in vitro. J Cell Biol 1990, 11:721-729.
122. Schaller M.D., Otey C.A., Hildebrand J.D., Parsons J.T. Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains. J Cell Biol 1995, 130:1181-1187.
123. Law D.A., Nannizzi-Alaimo L., Phillips D.R. Outside-in integrin signal transduction. αIIbβ3-(GPIIb-IIIa) tyrosine phosphorylation induced by platelet aggregation. J Biol Chem 1996, 271:10811-10815.
124. Cowan K.J., Law D.A., Phillips D.R. Identifi - cation of Shc as the primary protein binding to the tyrosinephosphorylated β3 subunit of αIIbβ3 during outside-in integrin platelet signaling. J Biol Chem 2000, 275:36423-36429.
125. Obergfell A., Eto K., Mocsai A., et al. Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb [beta]3 initiate integrin signaling to the cytoskeleton. J Cell Biol 2002, 157:265-275.
126. de V.M., Kiosses W.B., Shattil S.J. Proximal, selective, and dynamic interactions between integrin alpha-IIbbeta3 and protein tyrosine kinases in living cells. J Cell Biol 2004, 165:305-311.
127. Arias-Salgado E.G., Lizano S., Sarkar S., et al. Src kinase activation by direct interaction with the integrin beta cytoplasmic domain. Proc Natl Acad Sci USA 2003, 100:13298-13302.
128. Hannigan G.E., Leung-Hagesteijn C., Fitz-Gibbon L., et al. Regulation of cell adhesion and anchoragedependent growth by a new β1-integrin-linked protein kinase. Nature 1996, 379:91-96.
129. Vijayan K.V., Liu Y., Li T.T., Bray P.F. Protein phosphatase 1 associates with the integrin alphaIIb subunit and regulates signaling. J Biol Chem 2004, 279:33039-33042.
130. Kahn M.J., Kieber-Emmons T., Vilaire G., et al. Effect of mutagenesis of GPIIb amino acid 273 on the expression and conformation of the platelet integrin GPIIb-IIIa. Biochemistry 1996, 35:14304-14311.
131. Leung-Hagesteijn C.Y., Milankov K., Michalak M., Wilkins J., Dedhar S. Cell attachment to extracellular matrix substrates is inhibited upon downregulation of expression of calreticulin, an intracellular integrin alphasubunit-binding protein. J Cell Sci 1994, 107:589-600.
132. Rojiani M.V., Finlay B.B., Gray V., Dedhar S. Vitro interaction of a polypeptide homologous to human Ro/SS-A antigen (calreticulin) with a highly conserved amino acid sequence in the cytoplasmic domain of integrin α subunits. Biochemistry 1991, 30:9859-9866.
133. Shock D.D., Naik U.P., Brittain J.E., et al. Calcium-dependent properties of CIB binding to the integrin αIIb cytoplasmic domain and translocation to the platelet cytoskeleton. Biochem J 1999, 342:729-735.
134. Naik U.P., Patel P.M., Parise L.V. Identification of a novel calcium-binding protein that interacts with the integrin αIIb cytoplasmic domain. J Biol Chem 1997, 272:4651-4654.
135. Vallar L., Melchior C., Plancon S., et al. Divalent cations differentially regulate integrin αIIb cytoplasmic tail binding to β3 and to calcium-and integrin-binding protein. J Biol Chem 1999, 274:17257-17266.
136. Larkin D., Murphy D., Reilly D.F., et al. ICln, a novel integrin alphaIIbbeta3-associated protein, functionally regulates platelet activation. J Biol Chem 2004, 279:27286-27293.
137. Shattil S.J., O'Toole T., Eigenthaler M., et al. Beta 3-endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin beta 3 subunit. J Cell Biol 1995, 13:807-816.
138. Eigenthaler M., Hofferer L., Shattil S.J., Ginsberg M.H. A conserved sequence motif in the integrin beta3 cytoplasmic domain is required for its specific interaction with beta3-endonexin. J Biol Chem 1997, 272:7693-7698.
139. Kato A., Kawamata N., Tamayose K., et al. Ancient ubiquitous protein 1 binds to the conserved membraneproximal sequence of the cytoplasmic tail of the integrin alpha subunits that plays a crucial role in the inside-out signaling of alpha IIbbeta 3. J Biol Chem 2002, 277:28934-28941.
140. Burridge K., Chrzanowska-Wodnicka M. Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 1996, 12:463-518.
141. Priddle H., Hemmings L., Monkley S., et al. Disruption of the talin gene compromises focal adhesion assembly in undifferentiated but not differentiated embryonic stem cells. J Cell Biol 1998, 142:1121-1133.
142. Monkley S.J., Zhou X.H., Kinston S.J., et al. Disruption of the talin gene arrests mouse development at the gastrulation stage. Dev Dyn 2000, 219:560-574.
143. Pearson M.A., Reczek D., Bretscher A., Karplus P.A. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 2000, 101:259-270.
144. Garcia-Alvarez B., de Pereda J.M., Calderwood D.A., et al. Structural determinants of integrin recognition by talin. Mol Cell 2003, 11:49-58.
145. Calderwood D.A., Yan B., de Pereda J.M., et al. The phosphotyrosine binding (PTB)-like domain of talin activates integrins. J Biol Chem 2002, 277:21749-21758.
146. Tadokoro S., Shattil S.J., Eto K., et al. Talin binding to integrin β tails: A fi nal common step in integrin activation. Science 2003, 302:103-106.
147. Ulmer T.S., Calderwood D.A., Ginsberg M.H., Campbell I.D. Domain-specific interactions of talin with the membrane-proximal region of the integrin beta3 subunit. Biochemistry 2003, 42:8307-8312.
148. Xing B., Jedsadayanmata A., Lam S.C. Localization of an integrin binding site to the C terminus of talin. J Biol Chem 2001, 276:44373-44378.
149. Yan B., Calderwood D.A., Yaspan B., Ginsberg M.H. Calpain cleavage promotes talin binding to the beta 3 integrin cytoplasmic domain. J Biol Chem 2001, 276:28164-28170.
150. Martel V., Racaud-Sultan C., Dupe S., et al. Conformation, localization, and integrin binding of talin depend on its interaction with phosphoinositides. J Biol Chem 2001, 276:21217-21227.
151. Inomata M., Hayashi M., Ohno-Iwashita Y., et al. Involvement of calpain in integrin-mediated signal transduction. Arch Biochem Biophys 1996, 328:129-134.
152. Hayashi M., Suzuki H., Kawashima S., Saido T.C., Inomata M. The behavior of calpain-generated N-and C-terminal fragments of talin in integrin-mediated signaling pathways. Arch Biochem Biophys 1999, 371:133-141.
153. Kashiwagi H., Schwartz M.A., Eigenthaler M., et al. Affinity modulation of platelet integrin αIIbβ3 by β3-endonexin, a selective binding partner of the β3 integrin cytoplasmic tail. J Cell Biol 1997, 137:1433-1443.
154. Barry W.T., Boudignon-Proudhon C., Shock D.D., et al. Molecular basis of CIB binding to the integrin alpha IIb cytoplasmic domain. J Biol Chem 2002, 277:28877-28883.
155. Brown E., Hooper L., Ho T., Gresham H. Integrin-associated protein: A 50-kD plasma membrane antigen physically and functionally associated with integrins. J Cell Biol 1990, 111:2785-2794.
156. Zent R., Fenczik C.A., Calderwood D.A., et al. Class-and splice variant-specific association of CD98 with integrin beta cytoplasmic domains. J Biol Chem 2000, 275:5059-5064.
157. Dorahy D.J., Berndt M.C., Shafren D.R., Burns G.F. CD36 is spatially associated with glycoprotein IIb-IIIa (alpha IIb beta 3) on the surface of resting platelets. Biochem Biophys Res Commun 1996, 218:575-581.
158. Slupsky J.R., Seehafer J.G., Tang S.C., Masellis-Smith A., Shaw A.R. Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex. J Biol Chem 1989, 264:12289-12293.
159. Israels S.J., Millan-Ward E.M., Easton J., Robertson C., McNicol A. CD63 associates with the alphaIIb beta3 integrin-CD9 complex on the surface of activated platelets. Thromb Haemost 2001, 85:134-141.
160. Fitter S., Sincock P.M., Jolliffe C.N., Ashman L.K. Transmembrane 4 superfamily protein CD151 (PETA-3) associates with β1 and αIIbβ3 integrins in haemopoietic cell lines and modulates cell-cell adhesion. Biochem J 1999, 338:61-70.
161. Chung J., Gao A.G., Frazier W.A. Thrombospondin acts via integrin-associated protein to activate the platelet integrin αIIbβ3. J Biol Chem 1997, 272:14740-14746.
162. Dorahy D.J., Thorne R.F., Fecondo J.V., Burns G.F. Stimulation of platelet activation and aggregation by a carboxyl-terminal peptide from thrombospondin binding to the integrin-associated protein receptor. J Biol Chem 1997, 272:1323-1330.
163. Frazier W.A., Gao A.G., Dimitry J., et al. The thrombospondin receptor integrin-associated protein (CD47) functionally couples to heterotrimeric Gi. J Biol Chem 1999, 274:8554-8560.
164. Fenczik C.A., Sethi T., Ramos J.W., Hughes P.E., Ginsberg M.H. Complementation of dominant suppression implicates CD98 in integrin activation. Nature 1997, 390:81-85.
165. Huang M.M., Bolen J.B., Barnwell J.W., Shattil S.J., Brugge J.S. Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes proteintyrosine kinases in human platelets. Proc Natl Acad Sci USA 1991, 88:7844-7848.
166. Aiken M.L., Ginsberg M.H., Byers-Ward V., Plow E.F. Effects of OKM5, a monoclonal antibody to glycoprotein IV, on platelet aggregation and thrombospondin surface expression. Blood 1990, 76:2501-2509.
167. Leung L.L.K. Role of thrombospondin in platelet aggregation. J Clin Invest 1984, 74:1764-1772.
168. Lau L.M., Wee J.L., Wright M.D., et al. The tetraspanin superfamily member CD151 regulates outsidein integrin alphaIIbbeta3 signaling and platelet function. Blood 2004, 104:2368-2375.
169. Armulik A., Nilsson I., von Heijne G., Johansson S. Determination of the border between the transmembrane and cytoplasmic domains of human integrin subunits. J Biol Chem 1999, 274:37030-37034.
170. Sastry S.K., Horwitz A.F. Integrin cytoplasmic domains: Mediators of cytoskeletal linkages and extra-and intracellular initiated transmembrane signaling. Curr Opin Cell Biol 1993, 5:819-831.
171. O'Toole T.E., Mandelman D., Forsyth J., et al. Modulation of the affinity of integrin alphaIIIbbeta3 (GPIIb-IIIa) by the cytoplasmic domain of alphaIIIb. Science 1991, 254:845-847.
172. Hughes P.E., O'Toole T.E., Ylanne J., Shattil S.J., Ginsberg M.H. The conserved membrane-proximal region of an integrin cytoplasmic domain specifies ligand binding affinity. J Biol Chem 1995, 270:12411-12417.
173. Hughes P.E., Diaz-Gonzalez F., Leong L., et al. Breaking the integrin hinge. A defi ned structural constraint regulates integrin signaling. J Biol Chem 1996, 271:6571-6574.
174. Kim M., Carman C.V., Springer T.A. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 2003, 301:1720-1725.
175. Li R., Mitra N., Gratkowski H., et al. Activation of integrin αIIbβ3 by modulation of transmembrane helix associations. Science 2003, 300:795-798.
176. Luo B.H., Carman C.V., Takagi J., Springer T.A. Disrupting integrin transmembrane domain heterodimerization increases ligand binding affinity, not valency or clustering. Proc Natl Acad Sci USA 2005, 102:3679-3684.
177. Kamata T., Handa M., Sato Y., Ikeda Y., Aiso S. Membrane-proximal α/β stalk interactions differentially regulate integrin activation. J Biol Chem 2005, 280:24775-24783.
178. Luo B.H., Springer T.A., Takagi J. A specific interface between integrin transmembrane helices and affinity for ligand. PLoS Biol 2004, 2:776-786.
179. Litvinov R.I., Nagaswami C., Vilaire G., et al. Functional and structural correlations of individual alphaIIbbeta3 molecules. Blood 2004, 104:3979-3985.
180. Leisner T.M., Wencel-Drake J.D., Wang W., Lam S.C. Bidirectional transmembrane modulation of integrin αIIbβ3 conformations. J Biol Chem 1999, 274:12945-12949.
181. O'Toole T.E., Ylanne J., Culley B.M. Regulation of integrin affinity states through an NPXY motif in the β subunit cytoplasmic domain. J Biol Chem 1995, 270:8553-8558.
182. Chen Y.-P., Djaffar I., Pidard D., et al. Ser-752 → Pro mutation in the cytoplasmic domain of integrin β3 subunit and defective activation of platelet integrin αIIbβ3 (GPIIb-IIIa) in a variant of Glanzmann's thrombasthenia. Proc Natl Acad Sci USA 1992, 89:10169-10173.
183. Chen Y.P., O'Toole T.E., Shipley T., et al. Insideout" signal transduction initiated by isolated integrin cytoplasmic domains. J Biol Chem 1994, 269:18307-18310.
184. Fox J.E.B., Goll D.E., Reynolds C.C., Phillips D.R. Evidence that activation of platelet calpain is induced as a consequence of binding of adhesive ligand to the integrin, glycoprotein IIb-IIIa. J Cell Biol 1993, 120:1501-1507.